• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症相关转录因子 Runx2 与骨桥蛋白结合:切除骨肉瘤中的新型预后生物标志物。

The cancer-related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma.

机构信息

Department of Bone Disease, The Second Hospital of Tangshan, No.21, Jianshe North Road, Tangshan, 063000, China.

出版信息

Int J Clin Oncol. 2021 Dec;26(12):2347-2354. doi: 10.1007/s10147-021-02025-4. Epub 2021 Sep 21.

DOI:10.1007/s10147-021-02025-4
PMID:34546483
Abstract

PURPOSE

Osteosarcoma is the most common primary bone cancer in children and young adults. Recent experimental evidence has indicated that Runx2/OPN axis play important roles in the metastasis of osteosarcoma cells. The present study aimed to explore their relationship and prognostic significance in surgically resected osteosarcoma.

METHODS

The expression of runt-related transcription factor2(Runx2) and osteopontin (OPN) in clinical specimens from 105 osteosarcoma patients were detected by immunohistochemistry. The correlations between Runx2, OPN, and clinicopathologic data were analyzed by Chi-square (χ) tests. The prognostic values were determined by univariate and multivariate survival analysis. The accuracy of oncologic outcome prediction was evaluated by receiver-operating characteristics curves.

RESULTS

The results showed there is a significant positive correlation between Runx2 and OPN expression at protein levels (P = 0.015). Runx2 and OPN were both independent predictors for overall survival and metastasis-free survival. When Runx2 and OPN were taken into consideration together, the predictive range was extended and the sensitivity was improved, and more significant and better biomarkers for osteosarcoma metastasis and survival.

CONCLUSIONS

These results suggest that a combined Runx2/OPN expression could be a valuable independent predictor of tumor metastasis and survival in osteosarcoma patients.

摘要

目的

骨肉瘤是儿童和青少年中最常见的原发性骨癌。最近的实验证据表明,Runx2/OPN 轴在骨肉瘤细胞的转移中发挥重要作用。本研究旨在探讨其在手术切除的骨肉瘤中的关系和预后意义。

方法

采用免疫组织化学法检测 105 例骨肉瘤患者临床标本中 runt 相关转录因子 2(Runx2)和骨桥蛋白(OPN)的表达。采用卡方检验(χ2 检验)分析 Runx2、OPN 与临床病理资料的相关性。采用单因素和多因素生存分析确定预后价值。通过受试者工作特征曲线评估肿瘤学结局预测的准确性。

结果

结果表明,Runx2 和 OPN 在蛋白水平上的表达呈显著正相关(P = 0.015)。Runx2 和 OPN 都是总生存和无转移生存的独立预测因素。当同时考虑 Runx2 和 OPN 时,预测范围扩大,敏感性提高,是骨肉瘤转移和生存的更显著和更好的生物标志物。

结论

这些结果表明,Runx2/OPN 表达的联合可以作为骨肉瘤患者肿瘤转移和生存的有价值的独立预测因子。

相似文献

1
The cancer-related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma.癌症相关转录因子 Runx2 与骨桥蛋白结合:切除骨肉瘤中的新型预后生物标志物。
Int J Clin Oncol. 2021 Dec;26(12):2347-2354. doi: 10.1007/s10147-021-02025-4. Epub 2021 Sep 21.
2
The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis.癌症相关转录因子 RUNX2 调节骨肉瘤细胞中细胞外基质蛋白骨桥蛋白的表达和分泌,促进其与肺内皮细胞的黏附及肺转移。
J Cell Physiol. 2019 Aug;234(8):13659-13679. doi: 10.1002/jcp.28046. Epub 2019 Jan 13.
3
The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin.维生素D受体、Runx2和Notch信号通路在骨桥蛋白的转录调控中协同作用。
J Biol Chem. 2005 Dec 9;280(49):40589-98. doi: 10.1074/jbc.M504166200. Epub 2005 Sep 29.
4
Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma.免疫组化检测Runx2表达在骨肉瘤中的预后意义
Tumori. 2009 May-Jun;95(3):311-6. doi: 10.1177/030089160909500307.
5
Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.骨涎蛋白和骨桥蛋白对中国非小细胞肺癌患者切除术后骨转移的预测意义:一项大型队列回顾性研究。
Lung Cancer. 2010 Jan;67(1):114-9. doi: 10.1016/j.lungcan.2009.03.017.
6
Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection.骨桥蛋白联合 CD44v6,一种非小细胞肺癌根治性切除术后新的预后生物标志物。
Ann Thorac Surg. 2013 Dec;96(6):1943-51. doi: 10.1016/j.athoracsur.2013.07.089. Epub 2013 Oct 3.
7
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.骨桥蛋白和血小板反应蛋白-1在促进原发性切除非小细胞肺癌的肿瘤侵袭性方面发挥相反作用。
BMC Cancer. 2016 Jul 15;16:483. doi: 10.1186/s12885-016-2541-5.
8
Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.骨桥蛋白和血管内皮生长因子在非小细胞肺癌患者中的表达及其临床和预后意义
Cancer Epidemiol. 2015 Aug;39(4):539-44. doi: 10.1016/j.canep.2015.05.010. Epub 2015 Jun 27.
9
Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells.Ets-1和runx2调节小鼠结肠癌细胞中一种转移基因骨桥蛋白的转录。
J Biol Chem. 2006 Jul 14;281(28):18973-82. doi: 10.1074/jbc.M511962200. Epub 2006 May 1.
10
Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.骨桥蛋白和血管内皮生长因子在良性与恶性骨肿瘤中的表达
Virchows Arch. 2002 Oct;441(4):345-9. doi: 10.1007/s00428-002-0671-4. Epub 2002 Jul 3.

引用本文的文献

1
Serum Osteopontin as a Potential Marker for Metastasis and Prognosis in Primary Osteogenic Sarcoma: A Systematic Review.血清骨桥蛋白作为原发性骨肉瘤转移和预后的潜在标志物:一项系统综述
Cureus. 2024 May 18;16(5):e60544. doi: 10.7759/cureus.60544. eCollection 2024 May.
2
Collagen type X expression and chondrocyte hypertrophic differentiation during OA and OS development.骨关节炎(OA)和骨肉瘤(OS)发展过程中X型胶原蛋白的表达及软骨细胞肥大分化
Am J Cancer Res. 2024 Apr 15;14(4):1784-1801. doi: 10.62347/JWGW7377. eCollection 2024.
3
Osteopontin promotes gastric cancer progression phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.

本文引用的文献

1
RUNX2 (6p21.1) amplification in osteosarcoma.RUNX2(6p21.1)在骨肉瘤中的扩增。
Hum Pathol. 2019 Dec;94:23-28. doi: 10.1016/j.humpath.2019.09.010. Epub 2019 Oct 25.
2
Osteopontin as a biomarker for osteosarcoma therapy and prognosis.骨桥蛋白作为骨肉瘤治疗和预后的生物标志物。
Oncol Lett. 2019 Mar;17(3):2592-2598. doi: 10.3892/ol.2019.9905. Epub 2019 Jan 8.
3
The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis.
骨桥蛋白通过磷脂酰肌醇-3-激酶/蛋白激酶B/雷帕霉素哺乳动物靶标信号通路促进胃癌进展。
World J Gastrointest Oncol. 2023 Sep 15;15(9):1544-1555. doi: 10.4251/wjgo.v15.i9.1544.
4
Datasets for the effects of RUNX2 silencing on transcriptomic and metabolomic profiles in SJSA-1 osteosarcoma cells.RUNX2基因沉默对SJSA-1骨肉瘤细胞转录组和代谢组图谱影响的数据集。
Data Brief. 2023 Aug 18;50:109500. doi: 10.1016/j.dib.2023.109500. eCollection 2023 Oct.
5
RUNX2 and Cancer.RUNX2 与癌症。
Int J Mol Sci. 2023 Apr 10;24(8):7001. doi: 10.3390/ijms24087001.
6
Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis.骨桥蛋白在骨肉瘤发生发展、转移和预后中的内分泌调节和代谢机制。
Front Endocrinol (Lausanne). 2023 Jan 13;13:1100063. doi: 10.3389/fendo.2022.1100063. eCollection 2022.
7
The Oncogenic and Tumor Suppressive Long Non-Coding RNA-microRNA-Messenger RNA Regulatory Axes Identified by Analyzing Multiple Platform Omics Data from Cr(VI)-Transformed Cells and Their Implications in Lung Cancer.通过分析六价铬转化细胞的多平台组学数据鉴定出的致癌和抑癌长链非编码RNA-微小RNA-信使RNA调控轴及其在肺癌中的意义
Biomedicines. 2022 Sep 20;10(10):2334. doi: 10.3390/biomedicines10102334.
8
Hyaluronic Acid Correlates With Bone Metastasis and Predicts Poor Prognosis in Small-Cell Lung Cancer Patients.透明质酸与小细胞肺癌患者的骨转移相关,并预示不良预后。
Front Endocrinol (Lausanne). 2022 Jan 26;12:785192. doi: 10.3389/fendo.2021.785192. eCollection 2021.
癌症相关转录因子 RUNX2 调节骨肉瘤细胞中细胞外基质蛋白骨桥蛋白的表达和分泌,促进其与肺内皮细胞的黏附及肺转移。
J Cell Physiol. 2019 Aug;234(8):13659-13679. doi: 10.1002/jcp.28046. Epub 2019 Jan 13.
4
Osteopontin -- a promising biomarker for cancer therapy.骨桥蛋白——一种有前景的癌症治疗生物标志物。
J Cancer. 2017 Jul 15;8(12):2173-2183. doi: 10.7150/jca.20480. eCollection 2017.
5
Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma.CXCR4与MMP9的共表达预示着骨肉瘤切除术后肺转移及预后不良。
Tumour Biol. 2016 Apr;37(4):5089-96. doi: 10.1007/s13277-015-4352-8. Epub 2015 Nov 6.
6
New small molecules targeting apoptosis and cell viability in osteosarcoma.靶向骨肉瘤细胞凋亡和细胞活力的新型小分子
PLoS One. 2015 Jun 3;10(6):e0129058. doi: 10.1371/journal.pone.0129058. eCollection 2015.
7
Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma.人骨肉瘤中 WW0X、RUNX2 和 VEGFA 蛋白表达的相关性。
BMC Med Genomics. 2013 Dec 15;6:56. doi: 10.1186/1755-8794-6-56.
8
The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines.癌症相关转录因子 Runx2 调节人骨肉瘤细胞系的细胞增殖。
J Cell Physiol. 2013 Apr;228(4):714-23. doi: 10.1002/jcp.24218.
9
Runt-related transcription factor 2 in human colon carcinoma: a potent prognostic factor associated with estrogen receptor.Runt 相关转录因子 2 在人结肠癌中的表达:与雌激素受体相关的一个强有力的预后因子。
Int J Cancer. 2012 Nov 15;131(10):2284-93. doi: 10.1002/ijc.27525. Epub 2012 Apr 17.
10
The Role of RUNX2 in Osteosarcoma Oncogenesis.RUNX2在骨肉瘤发生中的作用。
Sarcoma. 2011;2011:282745. doi: 10.1155/2011/282745. Epub 2010 Dec 9.